WAGO 2026 Oral Poster Tour

Thursday, June 18, 2026 | 7:15 am – 7:44 am PT

Poster #1

Survival outcomes of gynecologic oncology patients treated with immune checkpoint inhibitors who received SARS-CoV2 vaccination

Presenting Author: Madison Klavans, MD, University of Virginia

Poster #2

Ovarian cancer patients with intellectual and developmental disabilities and Alzheimer’s disease and related disorders have worse survival and are less likely to receive guideline-adherent cancer care

Presenting Author: Lila Marshall, MD, University of California Irvine

Poster #3

Cost-effectiveness of early Lynch Syndrome screening at time of obstetrical prenatal carrier screening for maternal cancer prevention

Presenting Author: Binh T. Luu, BS, Oregon Health & Science University

Poster #4

Practice Patterns for Patients Diagnosed with Gynecologic Cancer and Co-existing Intellectual/Developmental Disabilities

Presenting Author: Katherine Jane Chua, MD, University of California Davis Health System

Poster #5

Evaluation of a Guided Imagery-Based Study Aid for Understanding Gynecological Cancer Staging

Presenting Author: Megan E. Lewis, MD, Kern Medical Center, Department of OB/Gyn

Thursday, June 18, 2026 | 9:30 am – 9:47 am PT

Poster #6

A cohort study assessing the impact of glucagon like-peptide 1 receptor agonist and progestin therapy on endometrial intraepithelial neoplasia and low-grade endometrial cancer

Presenting Author: Rohan Luhar, MD, MS, LAG Medical Center / Keck Hospital

Poster #7

Assessing benefit of lenvatinib and pembrolizumab after prior immunotherapy for recurrent endometrial cancer

Presenting Author: Maryam Ali, MD, UC Davis Health

Poster #8

Treatment with neoadjuvant chemotherapy for patients with Stage III endometrial cancer is associated with multiple clinical and sociodemographic factors, and with significantly worse overall survival, compared to primary surgery

Presenting Author: Patrick Penalosa, MD, Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of California, San Diego

Thursday, June 18, 2026 | 9:30 am – 9:47 am PT

Poster #13

Oncofertility referrals and obstetric outcomes in women with rare ovarian malignancies.

Presenting Author: Alexander Frumovitz, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center

Poster #14

Improving Timely Adjuvant Chemotherapy After Cytoreductive Surgery for Ovarian Cancer: Evaluation of an SGO Quality Indicator in a Rural Academic–Community Setting

Presenting Author: Austin M. Garcia, MD, UCSF Fresno Obstetrics and Gynecology

Poster #15

BMI1 Mediation of Chemoresistance through DNA Damage Repair Mechanisms in a Patient-Derived Ovarian Cancer Cell Line

Presenting Author: Ethan Nyein, MD, Loma Linda University

Friday, June 19, 2026 | 9:30 am – 9:52 am PT

Poster #36

Paclitaxel and anti-emetic hypersensitivity reaction rates in gynecologic oncology patients: a quality improvement project

Presenting Author: Riley Miller, Temple University Lewis Katz School of Medicine

Poster #37

Assessment of the LACE+ score as a predictor of 30-day readmission in gynecologic oncology patients

Presenting Author: Lauren Falk, University of Oklahoma Stephenson Cancer Center

Thursday, June 18, 2026 | 9:30 am – 9:47 am PT

Poster #61

Use of decision tree analysis to prioritize rurality for intervention among geography-based barriers to outpatient specialty palliative care referrals for patients with gynecologic cancers.

Presenting Author: Hannah Nettelblad, University of Kansas

Poster #62

Barriers and facilitators to cervical cancer screening among American Indian/Alaska Native individuals aged 50-64 years

Presenting Author: Jessica Currier, Oregon Health & Science University, Knight Cancer Institutes

Poster #63

Primary HPV Screening Outcomes in a Large Safety-Net Health System

Presenting Author: Jo Kaur, UCLA